AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Applied bioTechnology has reported promising results from an experimental vaccine in monkeys with AIDS, through a joint research project with the New England Regional Primate Research Center of Harvard Medical School (see BBJ, June 18, 1990).
The Cambridge company's recombinant vaccinia virus vaccine, as reported in the April 19 issue of Science magazine, elicits a response from both antibodies and the cellular immune system. That means it could both neutralize the AIDS virus itself and eliminate infected cells, according to Dennis Panicali, AbT's vice president of …